Opportunities Fund

UK's leading skincare specialist

sk:n, founded in 1986, is the UK’s largest trusted network of dermatology clinics offering an extensive range of medically-led treatments across the country, including laser hair / tattoo removal, dermatology and rejuvenation amongst others, and serving over 80,000 active clients per year.

The company has the highest level of clinical involvement in the market, underpinning its differentiated medically-led proposition, which is aligned with its target consumer prioritisation of clinical quality over price.

In February, 2019, TriSpan announced that it had successfully concluded the acquisition of sk:n from Graphite Capital via the TriSpan Opportunities Fund. At closing, sk:n had a UK wide portfolio of 51 clinics and 165 medically qualified personnel.

In May, 2019, the sk:n group announced the acquisition of Destination Skin, a leading chain of 16 aesthetic skincare clinics. In July, 2019, the sk:n group announced yet another transaction as the group acquired the 7 Skin Health Spa and Flint+Flint Clinics. Both recent acquisitions are transformative steps in the evolution of the group and further consolidate the position of sk:n as by far the largest independent aesthetic skin clinic network in the UK with now 75 clinics in the portfolio, exactly 50% more than when TriSpan acquired sk:n on February 1st, 2019.

“sk:n is an ambitious brand with exciting plans to grow over the coming years and TriSpan’s strategic approach is a perfect fit for our business. We’re very excited to take sk:n to the next level and confident that the combination of our highly experienced team with TriSpan’s experience in rollouts, plus its network and its international exposure will enable us to propel the business forward.”

Darren Grassby, CEO

Press Release Company Website